Chembio shares slump as FDA revokes emergency use of COVID-19 test

Chembio shares slump as FDA revokes emergency use of COVID-19 test

Reuters India

Published

Shares of Chembio Diagnostics Inc slumped more than 60% on Wednesday after the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization for its COVID-19 antibody test kit on concerns about its accuracy.

Full Article